Gillan M G, Robson L E, McKnight A T, Kosterlitz H W
Neuropeptides. 1985 Feb;5(4-6):533-6. doi: 10.1016/0143-4179(85)90072-1.
[3H]-Dynorphin A (1-8) was degraded in brain homogenates at 25 degrees and even at 0 degree C. The peptidase inhibitors bestatin and captopril almost completely protected[3H]-dynorphin A (1-8) from degradation at 0 degree C but had only little effect on binding at this temperature. At 25 degrees C, the binding of [3H]-dynorphin A (1-8) was markedly improved by addition of bestatin, captopril and L-leucyl-L-arginine, which afforded some, but not complete protection from degradation. The results of saturation binding assays at 25 degrees C in the presence of the peptidase inhibitors were variable. However, it was found from saturation binding assays at 0 degree C that the maximum binding capacity for [3H]-dynorphin A (1-8) at the kappa-site is similar to that of [3H]-(-)-bremazocine and [3H]-dynorphin A (1-9).
[3H] -强啡肽A(1 - 8)在25℃甚至0℃的脑匀浆中会发生降解。肽酶抑制剂抑氨肽酶素和卡托普利在0℃时几乎能完全保护[3H] -强啡肽A(1 - 8)不被降解,但在该温度下对其结合作用影响甚微。在25℃时,添加抑氨肽酶素、卡托普利和L -亮氨酰 - L -精氨酸可显著改善[3H] -强啡肽A(1 - 8)的结合,这些物质能提供一定程度但并非完全的降解保护。在25℃存在肽酶抑制剂的情况下进行饱和结合试验,结果各不相同。然而,通过在0℃进行饱和结合试验发现,[3H] -强啡肽A(1 - 8)在κ位点的最大结合容量与[3H] -( - ) -布马佐辛和[3H] -强啡肽A(1 - 9)相似。